Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Brian P Tullius"'
Autor:
Dean A Lee, Jeremiah L Oyer, Md Faqrul Hasan, Tayler J Croom-Perez, Liza D Robles-Carrillo, Sanjana Kumar, Brendan W Andersen, Brian P Tullius, Alicja J Copik, Amanda R Campbell, Thomas A Dieffenthaller, Catherine A Cash, Jonathan E Eloriaga, Meisam Naeimi Kararoudi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 12 (2023)
Background Inhibitory receptor T-cell Immunoreceptor with Ig and ITIM domains (TIGIT) expressed by Natural Killer (NK) and T cells regulates cancer immunity and has been touted as the next frontier in the development of cancer immunotherapeutics. Alt
Externí odkaz:
https://doaj.org/article/4c6550d3cfe540f09ffbff19f9a789fa
Autor:
Jeremiah L Oyer, Tayler J Croom-Perez, Liza D Robles-Carrillo, Faqrul Hasan, Sanjana Kumar, Brendan W Andersen, Javier A Rivera-Huertas, Brian P Tullius, Alicja J Copik
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e63b7da5f22e44cc8ce962614d25561c
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-19 (2021)
Abstract The adoptive transfer of natural killer (NK) cells is an emerging therapy in the field of immuno-oncology. In the last 3 decades, NK cells have been utilized to harness the anti-tumor immune response in a wide range of malignancies, most not
Externí odkaz:
https://doaj.org/article/9ca33b7b7c014e85a07ebd899d4cbefa
Autor:
Ezgi Elmas, Noushin Saljoughian, Marcelo de Souza Fernandes Pereira, Brian P. Tullius, Kinnari Sorathia, Robin J. Nakkula, Dean A. Lee, Meisam Naeimi Kararoudi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Antitumor activity of immune cells such as T cells and NK cells has made them auspicious therapeutic regimens for adaptive cancer immunotherapy. Enhancing their cytotoxic effects against malignancies and overcoming their suppression in tumor microenv
Externí odkaz:
https://doaj.org/article/790d417c9d5a46eeac12a7c7b8adf566
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-19 (2021)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
The adoptive transfer of natural killer (NK) cells is an emerging therapy in the field of immuno-oncology. In the last 3 decades, NK cells have been utilized to harness the anti-tumor immune response in a wide range of malignancies, most notably with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2d6bea75e50516835af4981c9e8d523
https://doi.org/10.1186/s13287-021-02277-x
https://doi.org/10.1186/s13287-021-02277-x
Autor:
Nitin Chakraravarti, Elie Haddad, Brian P. Tullius, Yaya Chu, Dean A. Lee, Aurelien B. L. Colamartino, Emily J. Pomeroy, Mitchell S. Cairo, Kathie Béland, Meisam Naeimi Kararoudi, Branden S. Moriarity
Publikováno v:
Semin Hematol
Cancer immunotherapy using genetically modified immune cells such as those expressing chimeric antigen receptors has shown dramatic outcomes in patients with refractory and relapsed malignancies. Natural killer (NK) cells as a member of the innate im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf91d58282eb68d5a10e7f652e4eea5
https://pubmed.ncbi.nlm.nih.gov/33256913
https://pubmed.ncbi.nlm.nih.gov/33256913
Publikováno v:
Advances in experimental medicine and biology. 1257
Natural killer (NK) cells are lymphocytes of the innate immune system that have the ability to recognize malignant cells through balanced recognition of cell-surface indicators of stress and danger. Once activated through such recognition, NK cells r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5fc46c6e4fe7d5f1eb9b13dfaabb8023
https://pubmed.ncbi.nlm.nih.gov/32483737
https://pubmed.ncbi.nlm.nih.gov/32483737
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783030430313
Natural killer (NK) cells are lymphocytes of the innate immune system that have the ability to recognize malignant cells through balanced recognition of cell-surface indicators of stress and danger. Once activated through such recognition, NK cells r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dc4d314317aeaec6b6b09290ce94d8a
https://doi.org/10.1007/978-3-030-43032-0_12
https://doi.org/10.1007/978-3-030-43032-0_12
Publikováno v:
Cancer Drug Resistance.
Evasion of immune surveillance is one of the hallmarks of cancer. Although the adaptive immune system has been targeted via checkpoint inhibition, many patients do not sustain durable remissions due to the heterogeneity of the tumor microenvironment,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6f71e9373d708d46312aea679d4f6e2
https://doi.org/10.20517/cdr.2020.12
https://doi.org/10.20517/cdr.2020.12
Autor:
Jay Michael S. Balagtas, Uma H. Athale, Brian P. Tullius, Joseph S. Palumbo, C. Heleen van Ommen, Anthony K.C. Chan
Publikováno v:
Journal of Thrombosis and Haemostasis. 16:175-180
Thromboprophylaxis to prevent cancer-associated venous thromboembolism (VTE) is well described in adult cancer patients. However, there is limited data and guidance available on prophylaxis of cancer-associated VTE in children. This statement therefo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f681e21f5d7b0148ec450e2b3638eb0
https://doi.org/10.1111/jth.13895
https://doi.org/10.1111/jth.13895